Rapid transcranial magnetic stimulation and normalization of the dexamethasone suppression test

Psychiatry and Clinical Neurosciences

Volumn 53, Issue 1, 1999, Pages 33-37

  Pridmore, Saxby ^a  

^a ROYAL HOBART HOSPITAL   (Australia)

Author keywords

Dexamethasone suppression test; Transcranial magnetic stimulation

Indexed keywords

ALPRAZOLAM; DEXAMETHASONE; HYDROCORTISONE; LITHIUM; LORAZEPAM; MOCLOBEMIDE; PAROXETINE; SERTRALINE; TRIMIPRAMINE; VALPROIC ACID; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MALE; MANIC DEPRESSIVE PSYCHOSIS; PROSPECTIVE STUDY; REMISSION; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGE FACTORS; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; DIAGNOSTIC TECHNIQUES, ENDOCRINE; ELECTRIC STIMULATION THERAPY; ELECTROMAGNETIC FIELDS; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION;

EID: 0032942028     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.1999.00467.x     Document Type: Article

References (24)

1. Carroll B, Feinberg M, Greden J et al. A specific laboratory test for the diagnosis of melancholia. Arch. Gen. Psychiatry 1981; 38: 15-22.
2. American Psychiatric Association Task Force on Laboratory Tests in Psychiatry. The dexamethasone suppression test: An overview of its current status in psychiatry. Am. J. Psychiatry 1987; 144: 1253-1262.
3. Rush A, Giles D, Schlesser M et al. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. Biol. Psychiatry 1997; 41: 915-928.
4. Rush A, Weissenburger J. Melancholic symptom features and DSM-IV. Am. J. Psychiatry 1994; 151: 489-498.
5. Thase M, Dube S, Bowler K et al. Hypothalamic-pituitary-adrenocortical activity and response to cognitive behaviour therapy in undedicated, hospitalised depressed patients. Am. J. Psychiatry 1996; 153: 886-891.
6. Carroll B. The hypothalamic-pituitary-adrenal axis in depression. In: Davies B, Carroll B, Mowbray R (eds) Depressive Illness: Some Research Studies. Springfield, IL, Charles C Thomas, 1972; 23-201.
7. Greden J, Gardner R, King D, Grunhaus L, Carroll B, Kronfol Z. Dexamethasone suppression tests in antidepressant treatment of melancholia. Arch. Gen. Psychiatry 1983; 40: 493-500.
8. Heuser I, Schweiger U, Gotthardt U et al. Pituitary-adrenal system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects. Am. J. Psychiatry 1996; 153: 93-99.
9. Ribeiro S, Tandon R, Grunhaus L, Greden J. The DST as a predictor of outcome in depression: A metaanalysis. Am. J. Psychiatry 1993; 150: 1618-1629.
10. Barden N, Reul J, Holsboer F. Do antidepressants stabilise mood thorough actions on the hypothalamic-Pituitary-adrenocortical system? Trends Neurosci. 1995; 18: 6-11.
11. Barker A, Jalinous R, Freeston I. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985; 1: 1106-1107.
12. George MS, Wassermann E, Post R. Transcranial magnetic stimulation: A neuropsychiatric tool for the 21st century. J. Neuropsychiatry Clin. Neurosci. 1996; 8: 373-382.
13. Kirkcaldie M, Pridmore S, Reid P. Electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS): The case of the skull. Convulsive Ther. 1997; 13: 83-91.
14. Pascual-Leone A, Rubio B, Pallardo F, Catala M. Beneficial effect of rapid-rate transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 1996; 348: 233-238.
15. George MS, Wassermann E, Kimbrell T et al. Daily left prefrontal rTMS improves mood in depression: A placebo-controlled crossover trial. Am. J. Psychiatry 1752; 1997: 154-156.
16. Padberg F, Haag C, Zwanzger P et al. Rapid and slow transcranial magnetic stimulation are equally effective in medication-resistant depression: A placebo-controlled study. Int. J. Neuropsychopharmacol. 1998; 1 (Suppl. 1): S30.
17. Montgomery S, Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 1979; 134: 1165-1171.
18. Zung W. A self-rating depression scale. Arch. Gen. Psychiatry 1965; 12: 63-70.
19. Fairchild C, Rush A, Vasavada N. Which depressions respond to placebo? Psychiatry Res. 1986; 18: 217-226.
20. Zimmerman M, Spitzer R. Melancholia: from DSM-III to DSM-III-R. Am. J. Psychiatry 1989; 146: 20-28.
21. von Bardeleben U, Holsboer F. Effect of age upon the steroid response to human CRH in depressed patients pre-treated with dexamethasone. Biol. Psychiatry 1991; 29: 1042-1050.
22. Heuser I, Gotthardt U, Schweiger U et al. Age-associated changes of pituitary-adrenocortical hormone regulation in humans: Importance of gender. Neurobiol. Aging 1994; 15: 227-231.
23. Figiel G, Epstein C, McDonald W et al. The use of rapid rate transcranial magnetic stimulation (rTMS) in refractory depressed patients. J. Neuropsychiatry Clin. Neurosci. 1998; 10: 20-25.
24. Grunhaus L, Dannon P, Schreiber S. Effects of transcranial magnetic stimulation on severe depression. Similarities with ECT. Biol. Psychiatry 1998; 43: 76S-77S.